Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis

Cited by (1,000)

Items 401–500 of 1,000

1. Physical activity as a vital sign in patients with bipolar disorder
   Davy Vancampfort, Michel Probst, Sabine Wyckaert, Marc D. Binder, Brendon Stubbs, Simon Rosenbaum, Pascal A. Sienaert · 2016 · Psychiatry Research
2. Metabolic syndrome and actigraphy measures of sleep and circadian rhythms in bipolar disorders during remission
   Héléna Brochard, Ophélia Godin, Pierre A. Geoffroy, Sunthavy Yeim, Carole Boudebesse, Chloé Benizri, Victoire Benard, Julia Maruani, Marion Leboyer, Frank Bellivier et al. · 2018 · Acta Psychiatrica Scandinavica
3. Less Medication Use in Inpatients With Severe Mental Illness Receiving a Multidisciplinary Lifestyle Enhancing Treatment. The MULTI Study III
   Jeroen Deenik, Diederik E. Tenback, Harold F. Van Driel, Erwin C. P. M. Tak, Ingrid J.M. Hendriksen, Peter N. van Harten · 2018 · Frontiers in Psychiatry
4. Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms
   V. Soontornniyomkij, Ellen E. Lee, Hua Jin, A. Martin, Rebecca Daly, Jinyuan Liu, X. Tu, L. Eyler, D. Jeste · 2019 · Frontiers in Psychiatry
5. Health Effects of an Individualized Lifestyle Intervention for People with Psychotic Disorders in Psychiatric Outpatient Services: A Two Year Follow-up
   Marjut Blomqvist, Andréas Ivarsson, Ing‐Marie Carlsson, Anna Sandgren, Henrika Jormfeldt · 2019 · Issues in Mental Health Nursing
6. The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome
   Stephen D. H. Malnick, Yaakov Maor · 2020 · Visceral Medicine
7. Multimorbidity and the Etiology of Schizophrenia
   Andreı̈ Szöke, Baptiste Pignon, Ophélia Godin, Aziz Ferchiou, Ryad Tamouza, Marion Leboyer, Franck Schürhoff · 2024 · Current Psychiatry Reports
8. Interventions to integrate care for people with serious mental illness and substance use disorders: a systematic scoping review protocol
   Amy Richardson, Lauralie Richard, Kathryn E. Gunter, Sarah Derrett · 2019 · BMJ Open
9. Clinical validation of the self-reported Glasgow Antipsychotic Side-effect Scale using the clinician-rated UKU side-effect scale as gold standard reference
   Marlene Schouby Bentestuen, Oona Nørgaard Van Achter, David E. Dines, Maria Simonsen Speed, Christoph Ulrich Correll, Ole N Mors, Søren Dinesen Østergaard, Pernille Kølbæk · 2020 · Journal of Psychopharmacology
10. Differences in patterns of metabolic abnormality and metabolic syndrome between early-onset and adult-onset first-episode drug-naive schizophrenia patients
    Xiaoe Lang, Yang Zhou, Lei Zhao, Yinjun Gu, Xi Lawrence Wu, Yuefeng Zhao, Zezhi Li, Xiangyang Zhang · 2021 · Psychoneuroendocrinology
11. Diagnosis of bipolar disorders and body mass index predict clustering based on similarities in cortical thickness—ENIGMA study in 2436 individuals
    Sean R. McWhinney, Christoph Abé, Martin Alda, Francesco Benedetti, Erlend Bøen, Caterina del Mar Bonnín, Tiana Borgers, Katharina Brosch, Erick Jorge Canales-Rodríguez, Dara M. Cannon et al. · 2021 · Bipolar Disorders
12. Hair cortisol levels in schizophrenia and metabolic syndrome
    Leigh L. van den Heuvel, Retha Smit, Tobias Stalder A, Clemens Kirschbaum, Soraya Seedat, Robin Alexander Emsley · 2022 · Early Intervention in Psychiatry
13. Hypertension and psychosis
    Yauvani Sudarshan, Bernard M.Y. Cheung · 2022 · Postgraduate Medical Journal
14. Drug–drug interactions involving combinations of antipsychotic agents with antidiabetic, lipid-lowering, and weight loss drugs
    A Buzea, Peter Manu, Lorena Dima, Christoph Ulrich Correll · 2022 · Expert Opinion on Drug Metabolism & Toxicology
15. Physical health policies and metabolic screening in mental health care systems of sub-Saharan African countries: a systematic review
    James Mugisha, Marc D. Binder, Brendon Stubbs, David Basangwa, Davy Vancampfort · 2017 · International Journal of Mental Health Systems
16. Sedentary behaviour, physical activity, cardiorespiratory fitness and cardiometabolic risk in psychosis: The PsychiActive project
    Javier Bueno‐Antequera, Miguel Ángel Oviedo‐Caro, Diego Munguía‐Izquierdo · 2017 · Schizophrenia Research
17. Relationship between objectively measured sedentary behavior and health outcomes in schizophrenia patients: The PsychiActive project
    Javier Bueno‐Antequera, Miguel Ángel Oviedo‐Caro, Diego Munguía‐Izquierdo · 2017 · Schizophrenia Research
18. Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in Switzerland
    Céline Dubath, Aurélie Delacrétaz, Anaïs Glatard, Péter Vollenweider, Martin Preisig, Hélène Richard-Lepouriel, Roland Hasler, Franziska Gamma, Alessandra Solida, Jacques Thonney et al. · 2020 · The Journal of Clinical Psychiatry
19. Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia
    Anastasiia S. Boiko, Irina A. Mednova, Elena G. Kornetova, Nikolay A. Bokhan, Arkadiy V. Semke, ANTON J. M. LOONEN, Svetlana А. Ivanova · 2020 · Neuropsychiatric Disease and Treatment
20. One‐year aerobic interval training in outpatients with schizophrenia: A randomized controlled trial
    Mathias Forsberg Brobakken, Mona Nygård, Ismail Cüneyt Güzey, Gunnar Morken, Solveig Klæbo Reitan, Jørn Heggelund, Einar Vedul‐Kjelsås, Eivind Wang · 2020 · Scandinavian Journal of Medicine and Science in Sports
21. The Development of a Nutrition Screening Tool for Mental Health Settings Prone to Obesity and Cardiometabolic Complications: Study Protocol for the NutriMental Screener
    Scott B. Teasdale, Sabrina Mörkl, Sonja Mötteli, Annabel Sandra Mueller‐Stierlin · 2021 · International Journal of Environmental Research and Public Health
22. Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics
    Christina V. Mangurian, Aishat Giwa, Erin Brosey, Martha Shumway, James Dilley, Elena Fuentes‐Afflick, Eliseo J. Pérez‐Stable, Dean Schillinger · 2019 · The Journal of the American Board of Family Medicine
23. The regulatory effects of second-generation antipsychotics on lipid metabolism: potential mechanisms mediated by the gut microbiota and therapeutic implications
    Chen, Hui, Cao, Ting, Zhang, Bikui, Cai, Hualin · 2023 · Frontiers in Pharmacology
24. Poor Oral Health in Patients with Schizophrenia: a Meta-Analysis of Case-Control Studies
    Xiaoni Sun, Jianbo Zhou, Na Li · 2020 · Psychiatric Quarterly
25. Isoquinolinone derivatives as potent CNS multi-receptor D2/5-HT1A/5-HT2A/5-HT6/5-HT7 agents: Synthesis and pharmacological evaluation
    Jian Jun Jin, Kun-Xiao Zhang, Fei Dou, Chao Hao, Yifang Zhang, Xudong Cao, Lanchang Gao, Jiaying Xiong, Xin Liu, Bi‐Feng Liu et al. · 2020 · European Journal of Medicinal Chemistry
26. Mega-analysis of association between obesity and cortical morphology in bipolar disorders: ENIGMA study in 2832 participants
    Sean R. McWhinney, Christoph Abé, Martin Alda, Francesco Benedetti, Erlend Bøen, Caterina del Mar Bonnín, Tiana Borgers, Katharina Brosch, Erick Jorge Canales-Rodríguez, Dara M. Cannon et al. · 2023 · Psychological Medicine
27. The Wicked Relationship between Depression and Metabolic Syndrome.
    Donatella Marazziti, Alessandro Arone, Stefania Palermo, Eric Annuzzi, Gabriele Cappellato, Ilaria Chiarantini, Luca Del Prete, Liliana Dell’Osso · 2023 · PubMed Central
28. Olanzapine and aripiprazole differentially affect glucose uptake and energy metabolism in human mononuclear blood cells
    Britta Stapel, Alexandra Kotsiari, Michaela Scherr, Denise Hilfiker‐Kleiner, Stefan Bleich, Helge Frieling, Kai G. Kahl · 2016 · Journal of Psychiatric Research
29. Monitoring oral health of people in Early Intervention for Psychosis (EIP) teams: The extended Three Shires randomised trial
    Clive Elliott Adams, Nicola Clark Wells, Andrew Clifton, Hannah F Jones, Jayne Simpson, Graeme E Tosh, Patrick Callaghan, Peter Francis Liddle, Boliang Guo, Vivek A Furtado et al. · 2017 · International Journal of Nursing Studies
30. Adipocytokines and ghrelin level of bipolar patients from manic episode to euthymic episode
    Özgür Korhan Tunçel, Gökhan Sarísoy, Birşen Bilgici, Ozan Pazvantoğlu, Eda Çetin, Ebru Kaynar Tunçel · 2017 · Nordic Journal of Psychiatry
31. Physical performance and physical activity of patients under compulsory forensic psychiatric inpatient care
    Henrik Bergman, Thomas Nilsson, Peter Andiné, Alessio Degl’Innocenti, Roland Thomeé, Annelie Gutke · 2018 · Physiotherapy Theory and Practice
32. Prevalence of metabolic syndrome and its associated risk factors in an African-Caribbean population with severe mental illness.
    Laura de Caluwé, Nora van Buitenen, P. Gelan, C. Crunelle, R. Thomas, Sharon Casseres, F. Matthys, P. Harten, W. Cahn · 2019 · Psychiatry Research
33. Physical health in affective disorders: a narrative review of the literature
    Lluc Colomer, Gerard Anmella, Eduard Vieta, Iría Grande · 2020 · Brazilian Journal of Psychiatry
34. Insomnia symptoms are associated with metabolic syndrome in patients with severe psychiatric disorders
    Wenjuan Zhang, Qimeng Sun, Baixin Chen, Maria Basta, XU Chong-tao, Yun Li · 2021 · Sleep Medicine
35. Smoking Affects the Patterns of Metabolic Disorders and Metabolic Syndrome in Patients With First-Episode Drug-Naive Schizophrenia: A Large Sample Study Based on the Chinese Han Population
    Zezhi Li, Shuning Wang, Yuping Chen, Xi Lawrence Wu, Yinjun Gu, Xiaoe Lang, Fengchun Wu, Xiangyang Zhang · 2021 · The International Journal of Neuropsychopharmacology
36. Evaluation of a training program to support the implementation of a community pharmacist-led support service for people living with severe and persistent mental illness
    Ricki Ng, Sarira El‐Den, Jack Charles Collins, Jie Hu, Sara S. McMillan, Amanda Wheeler, Claire Louise O’Reilly · 2023 · Journal of the American Pharmacists Association
37. ‘Walk This Way’ – a pilot of a health coaching intervention to reduce sedentary behaviour and increase low intensity exercise in people with serious mental illness: study protocol for a randomised controlled trial
    Julie Williams, Brendon Stubbs, Fiona Gaughran, Tom Craig · 2016 · Trials
38. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population
    Vikram Singh Rawat, Suhas Ganesh, Somashekar Bijjal, K. Shanivaram Reddy, Vikas Agarwal, Renuka Devi, Chennaveerachari Naveen Kumar, Rita Christopher, Jagadisha Thirthalli · 2017 · Schizophrenia Research
39. A higher body mass index in Chinese inpatients with chronic schizophrenia is associated with elevated plasma orexin-A levels and fewer negative symptoms
    Zhiwei Liu, Yulong Zhang, Tongtong Zhao, Juan Wang, Lei Xia, Yi Zhong, Yating Yang, Xiaoshuai Ning, Yelei Zhang, Zhenhua Ren et al. · 2020 · Nordic Journal of Psychiatry
40. Does Schizophrenia Itself Cause Obesity?
    Liang, Jiaquan, Cai, Yanshan, Xue, Xiongyan, Li, Xiaoling, Li, Zaifang, Xu, Caixia, Xie, Guojun, Yu, Yang · 2022 · Frontiers in Psychiatry
41. Blood pressure in bipolar disorder: evidence of elevated pulse pressure and associations between mean pressure and mood instability
    Niall M. McGowan, Molly Nichols, Amy C. Bilderbeck, Guy M. Goodwin, Kate Saunders · 2021 · International Journal of Bipolar Disorders
42. Melatonin and melatonin‐agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta‐analysis
    Alessandro Miola, Michele Fornaro, Fabio Sambataro, Marco Solmi · 2021 · Human Psychopharmacology Clinical and Experimental
43. Drug–drug interactions involving antipsychotics and antihypertensives
    A Buzea, Lorena Dima, Christoph Ulrich Correll, Peter Manu · 2022 · Expert Opinion on Drug Metabolism & Toxicology
44. Metabolic syndrome in patients with schizophrenia: Why should we care
    Jichao Liu, Lijuan Fu · 2022 · Medicine
45. Overcoming clozapine’s adverse events: a narrative review of systematic reviews and meta-analyses
    Timothy David Tanzer, Betty Pham, Nicola Warren, Michael A. Barras, Steve R Kisely, Dan J. Siskind · 2024 · Expert Opinion on Drug Safety
46. Lipid profiles in major depression, both with and without metabolic syndrome: associations with suicidal behaviors and neuroticism
    Ketsupar Jirakran, Asara Vasupanrajit, Chavit Tunvirachaisakul, Abbas Firras Almulla, Marta Kubera, Michael H. J. Maes · 2025 · BMC Psychiatry
47. Physical and mental health burden in cases of bipolar disorder classified as current, former, or non-tobacco smokers
    Romain Icick, Sébastien Gard, M. Barde, Mathilde Carminati, A. Desage, Sébastien Guillaume, Jan L. Scott, Frank Bellivier · 2016 · Journal of Affective Disorders
48. Exercise is medicine for depression: even when the “pill” is small
    Hallgren, Mats, Vancampfort, Davy, Stubbs, Brendon · 2016 · Neuropsychiatric Disease and Treatment
49. Genetic variants impacting metabolic outcomes among people on clozapine: a systematic review and meta-analysis
    Rachel J. Suetani, Dan J. Siskind, Heidi Reichhold, Steve R Kisely · 2017 · Psychopharmacology
50. Chronotropic incompetence of the heart is associated with exercise intolerance in patients with schizophrenia
    Marco Herbsleb, Andy Schumann, Berend Malchow, Christian Puta, Paul Christian Schulze, Holger W. Gabriel, Karl‐Jürgen Bär · 2018 · Schizophrenia Research
51. Exercise effects on cognitive functioning in young adults with first-episode psychosis: FitForLife
    Mats Å. Hallgren, Maria Skott, Örjan B. Ekblom, Joseph Firth, Adrian J. Schembri, Yvonne Forsell · 2018 · Psychological Medicine
52. Psychiatrists’ reflections on a medication-free program for patients with psychosis
    Rafal A.H. Yeisen, Jone Ravndal Bjørnestad, Inge Joa, Jan Olav Johannessen, Stein Opjordsmoen · 2019 · Journal of Psychopharmacology
53. Association between cognitive impairment and cardiovascular burden in patients with severe mental disorder
    Quintí Foguet Boreu, Anna Guàrdia-Sancho, Josep Manel Santos, Pere Roura Poch, Joan Palmarola Ginesta, Anna Maria Puig-Ribera, Jordina Muñoz-Padros · 2019 · Cognitive Neuropsychiatry
54. The Role of Proopiomelanocortin and α-Melanocyte-Stimulating Hormone in the Metabolic Syndrome in Psychiatric Disorders: A Narrative Mini-Review
    Stefan Raue, Dirk Wedekind, Jens Wiltfang, Ulrike Schmidt · 2019 · Frontiers in Psychiatry
55. Higher Body-Mass Index and Lower Gray Matter Volumes in First Episode of Psychosis
    Marián Kolenič, Filip Španiel, Jaroslav Hlinka, Martin Matějka, Pavel Knytl, Antonín Šebela, Jiří Renka, Tomáš Hájek · 2020 · Frontiers in Psychiatry
56. Kynurenine metabolism and metabolic syndrome in patients with schizophrenia
    Ping Zhang, Junchao Huang, Mengzhuang Gou, Yanfang Zhou, Jinghui Tong, Fengmei Fan, Yimin Cui, Xingguang Luο, Shuping Tan, Zhiren Wang et al. · 2021 · Journal of Psychiatric Research
57. Evaluation of major depression symptom networks using clinician-rated and patient-rated data
    Jacson Gabriel Feiten, Bruno Paz Mosqueiro, Mariana Uequed, Ives Cavalcante Passos, Marcelo Pio de Almeida Fleck, Marco Antônio Caldieraro · 2021 · Journal of Affective Disorders
58. Earlier age of onset is associated with a pro-inflammatory state in major depressive disorder
    Ana Paula Anzolin, Jacson Gabriel Feiten, Giovana Bristot, Gabriela Maria Pereira Possebon, Marcelo Pio de Almeida Fleck, Marco Antônio Caldieraro, Marcia Kauer‐Sant’Anna · 2022 · Psychiatry Research
59. Bidirectional longitudinal relationship between leisure-time physical activity and psychotropic medication usage: A register linked follow-up study
    Brendon Stubbs, Davy Vancampfort, Minna Mänty, Anna Svärd, Ossi Rahkonen, Jouni Lahti · 2016 · Psychiatry Research
60. Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation
    Kateřina Horská, Hana Kotolová, Michal Karpíšek, Zuzana Babinská, Tomáš Hammer, Jiří Herbert Procházka, Tibor Štark, Vincenzo Micale, Jana Kučerová · 2020 · Toxicology and Applied Pharmacology
61. Enhanced Predictive Value of Lipid Accumulation Product for Identifying Metabolic Syndrome in the General Population of China
    Qi Shao, Jing Li, Yi‐Ling Wu, Xing Liu, Na Wang, Yonggen Jiang, Qi Zhao, Genming Zhao · 2023 · Nutrients
62. Comparative predictive efficacy of atherogenic indices on metabolic syndrome in patients with schizophrenia
    Yu-Tung Tien, Liang‐Jen Wang, Yu Lee, Pao‐Yen Lin, Chi‐Fa Hung, Mian‐Yoon Chong, Yu‐Chi Huang · 2023 · Schizophrenia Research
63. Importance of good hosting: reviewing the bi-directionality of the microbiome-gut-brain-axis
    Carolina F. F. A. Costa, Joana Ferreira‐Gomes, Fernando Barbosa, Benedita Sampaio‐Maia, Philip W. J. Burnet · 2024 · Frontiers in Neuroscience
64. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort
    Pierre A. Geoffroy, Ophélia Godin, Diane Mahee, Chantal Henry, V. Aubin, Jean‐Michel Azorin, Thierry Bougerol, Philippe Courtet, Sébastien Gard, Jean‐Pierre Kahn et al. · 2017 · Chronobiology International
65. Pharmacological management of diabetes in severe mental illness: a comprehensive clinical review of efficacy, safety and tolerability
    John Lally, Aonghus O’ Loughlin, Brendon Stubbs, Allys Guérandel, Donal Brendan O'Shea, Fiona Gaughran · 2018 · Expert Review of Clinical Pharmacology
66. Child maltreatment, psychopathological symptoms, and onset of diabetes mellitus, hypothyroidism and COPD in adulthood
    Mashhood Ahmed Sheikh · 2018 · Journal of Affective Disorders
67. Prediction of Depression Scores From Aerobic Fitness, Body Fatness, Physical Activity, and Vagal Indices in Non-exercising, Female Workers
    Laís Tonello, Iransé Oliveira Silva, André Ricarte Medeiros, Arthur Ney Alves Donato, Felipe Barreto Schuch, Lars Donath, Daniel Alexandre Boullosa · 2019 · Frontiers in Psychiatry
68. Management of Cardiovascular Health in People with Severe Mental Disorders
    Cédric Lemogne, Jacques Blacher, Guillaume Airagnes, Nicolas Hoertel, Sébastien Czernichow, Nicolas Danchin, Pierre Meneton, Frédéric Limosin, Jess G. Fiedorowicz · 2021 · Current Cardiology Reports
69. The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety
    Yingbin Zhong, Manji Hu, Qiang Wang, Zhen-Dong Yang, Na Zhu, Fei Wang, Xi-Yan Zhang, Cheng-Fang Zhang, J. Min, Hao Wang et al. · 2021 · Scientific Reports
70. Increased pericardial adipose tissue and cardiometabolic risk in patients with schizophrenia versus healthy controls
    J. Ruppert, D Hartung, Mechthild Westhoff‐Bleck, J. Herrmann, Brendon Stubbs, J. Cordes, Tillmann H. C. Krüger, Ralf Lichtinghagen, Kai G. Kahl · 2017 · European Archives of Psychiatry and Clinical Neuroscience
71. Impact of aerobic exercise on muscle mass in patients with major depressive disorder: a randomized controlled trial
    Arno Kerling, Dagmar Hartung, Brendon Stubbs, Momme Kück, Uwe Tegtbur, Lena Grams, Thomas Sanjay Weber-Spickschen, Kai G. Kahl · 2018 · Neuropsychiatric Disease and Treatment
72. Associations of metabolic syndrome with depression are mediated by inflammation and oxidative stress: Findings from NHANES 2005–2018
    Minghui Li, Zhenyu Zhai · 2025 · Journal of Affective Disorders
73. Identification of genetic loci that overlap between schizophrenia and metabolic syndrome
    Honggang Lv, Juan Li, Kai Gao, Lingsi Zeng, Ranran Xue, Xia Liu, Cong Zhou, Weihua Yue, Hao Yu · 2022 · Psychiatry Research
74. Decreased FGF19 and FGF21: possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depression
    Mimi Tang, Shuqiao Cheng, Lu Wang, Hui Tang, Ting Liu, Tingyu Zhao, Rui-Li Dang · 2023 · Frontiers in Neuroscience
75. Long-term metabolic side effects of second-generation antipsychotics in Chinese patients with schizophrenia: A within-subject approach with modelling of dosage effects
    Kenneth Chi-Yin WONG, Perry B.M. Leung, Benedict Ka-Wa Lee, Pak Chung Sham, Simon S. Y. Lui, Hon‐Cheong So · 2024 · Asian Journal of Psychiatry
76. Effectiveness of an affect-adjusted, supervised, multimodal, online and home-based exercise group protocol for major depression: A randomized controlled trial
    Vagner Deuel de Oliveira Tavares, Felipe Barreto Schuch, Geovan Menezes de Sousa, Mats Å. Hallgren, Leônidas Oliveira Neto, Daniel A.R. Cabral, Raissa Nóbrega de Almeida, David Cavalcante Barbosa, Victor Rocha Nóbrega de Almeida, Hanna Gabriela Bezerra de Macêdo Tinôco et al. · 2024 · Psychology of sport and exercise
77. Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion
    M. Heslin, Anita Patel, D. Stahl, Poonam Gardner-Sood, M. Mushore, Shubulade Smith, K. Greenwood, O. Onagbesan, C. O'Brien, C. Fung et al. · 2017 · BMC Psychiatry
78. Patient perspectives on how living with a mental illness affects making and maintaining healthy lifestyle changes
    Bobbi Jo H. Yarborough, Scott P. Stumbo, Julie A. Cavese, Micah T. Yarborough, Carla A. Green · 2018 · Patient Education and Counseling
79. “Football is pure enjoyment”: An exploration of the behaviour change processes which facilitate engagement in football for people with mental health problems
    Jackie Hargreaves, Andy Pringle · 2019 · Mental health and physical activity
80. Cost-effectiveness of a lifestyle intervention for people with a serious mental illness (SMILE): design of a pragmatic cluster-randomised controlled trial
    Florine Sanna Walburg, Berno van Meijel, Maurits W. van Tulder, Marcel C. Adriaanse · 2019 · BMC Psychiatry
81. Physical health among patients with common mental health disorders in primary care in Europe: a scoping review
    F. Fogarty, Geoff McCombe, Katherine Brown, Thérèse van Amelsvoort, Mary Clarke, Walter Cullen · 2020 · Irish Journal of Psychological Medicine
82. Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric Hospitals
    Elena G. Kornetova, А. Н. Корнетов, Irina A. Mednova, Гончарова Анастасия Александровна, Valeria I. Gerasimova, Ivan V. Pozhidaev, Anastasiia S. Boiko, Arkadiy V. Semke, ANTON J. M. LOONEN, Nikolay A. Bokhan et al. · 2021 · Frontiers in Psychiatry
83. Impact of Lurasidone and Other Antipsychotics on Body Weight: Real-World, Retrospective, Comparative Study of 15,323 Adults with Schizophrenia
    Ilena Pochiero, Fabrizio Calisti, Alessandro Comandini, Alessandra Del Vecchio, Isabella Costamagna, Maria Teresa Rosignoli, Agnese Cattaneo, Sasikiran Nunna, Ilaria Peduto, Franca Heiman et al. · 2021 · International Journal of General Medicine
84. Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial
    Bhanu Gupta, Chee Kt, Li Qi Neo, Charmaine Yu Zheng Tang, Jayaraman Hariram, Geoffrey Chern-Yee Tan, Swapna Kamal Verma, Sutapa Basu, Deva Priya Appan, Chan-Chun Ting et al. · 2021 · Therapeutic Advances in Psychopharmacology
85. Orexin-a elevation in antipsychotic-treated compared to drug-free patients with schizophrenia: A medication effect independent of metabolic syndrome
    Po‐Yu Chen, Chin‐Kuo Chang, Chun-Hsin Chen, Su‐Chen Fang, Valeria Mondelli, Chih‐Chiang Chiu, Mong‐Liang Lu, Ling-Ling Hwang, Ming‐Chyi Huang · 2022 · Journal of the Formosan Medical Association
86. Prevalence of metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: Baseline results from the PAFIP cohort
    Nathalia Garrido Torres, Miguel Ruíz-Veguilla, Luis Alameda, Manuel Canal‐Rivero, María Juncal Ruiz, Marcos Gómez‐Revuelta, Rosa Ayesa‐Arriola, Ana Rubio-García, Benedicto Crespo‐Facorro, Javier Vázquez-Bourgón · 2022 · Schizophrenia Research
87. A quantitative assessment of the views of mental health professionals on exercise for people with mental illness: perspectives from a low-resource setting
    Davy Vancampfort, Robert Stanton, Michel Probst, Marc D. Binder, Ruud van Winkel, Inez Myin‐Germeys, Eugene Kinyanda, James Mugisha · 2019 · African Health Sciences
88. Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study
    Samer Hammoudeh, Hawra J. Al Lawati, Suhaila Ghuloum, Huma Iram, Arij Yehya, Imen Becetti, Nora AlFakhri, Hany Ghabrash, Mena Shehata, Nighat Ajmal et al. · 2019 · Community Mental Health Journal
89. Strategies to deal with comorbid physical illness in psychosis
    Mary Jane Docherty, Brendon Stubbs, Fiona Gaughran · 2016 · Epidemiology and Psychiatric Sciences
90. Reliability and validity of physical fitness tests in people with mental disorders: A systematic review and meta‐analysis
    Vagner Deuel de Oliveira Tavares, Davy Vancampfort, Mats Å. Hallgren, Andreas Heißel, Camilo Germán Alberto Pérez Chaparro, Marco Solmi, Gavin Daniel Tempest, Leônidas de Oliveira Neto, Nicole Leite Galvão Coelho, Joseph Firth et al. · 2021 · Physiotherapy Research International
91. Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort
    Marianne Foiselle, Susana Barbosa, Ophélia Godin, Ching‐Lien Wu, Wahid Boukouaci, Myrtille André, Bruno Aouizerate, Fabrice Sébastien Berna, Caroline Barau, Delphine Capdevielle et al. · 2022 · Brain Behavior & Immunity - Health
92. Metabolic Hormones in Schizophrenia Patients with Antipsychotic-Induced Metabolic Syndrome
    Anastasiia S. Boiko, Irina A. Mednova, Elena G. Kornetova, Гончарова Анастасия Александровна, Arkadiy V. Semke, Nikolay A. Bokhan, Svetlana А. Ivanova · 2022 · Journal of Personalized Medicine
93. Predictors of adherence to exercise interventions in people with schizophrenia
    Rebecca Schwaiger, Isabel Maurus, Moritz Lembeck, Irina Papazova, David Greska, Susanne Muenz, Eliska B. Sykorova, Cristina E. Thieme, Bob O. Vogel, Sebastian Mohnke et al. · 2024 · European Archives of Psychiatry and Clinical Neuroscience
94. Temporal trends in the burden of musculoskeletal diseases in China from 1990 to 2021 and predictions for 2021 to 2030
    Yunfa Wang, Bofan Chen, Xinyue Liu, Haimin Zeng, Бин Чэн, Zhilin Wang, Qingpiao Yang, Jie Peng, Liang Hao · 2024 · Bone
95. Perceived barriers, benefits and correlates of physical activity in outpatients with Major Depressive Disorder: A study from Brazil
    Fernanda Castro Monteiro, Felipe Barreto Schuch, Andréa Camaz Deslandes, Davy Vancampfort, Bruno Paz Mosqueiro, Mateus Frizzo Messinger, Marco Antônio Caldieraro, Marcelo Pio de Almeida Fleck · 2020 · Psychiatry Research
96. The Physical Health Care Fidelity Scale: Psychometric Properties
    Torleif Ruud, Tordis Sørensen Høifødt, Delia Cimpean Hendrick, Robert E. Drake, Anne Høye, Matthew Landers, Kristin Sverdvik Heiervang, Gary R. Bond · 2020 · Administration and Policy in Mental Health and Mental Health Services Research
97. Metabolic syndrome components and leukocyte telomere length in patients with major depressive disorder
    Yu‐Chi Huang, Pao‐Yen Lin, Yu Lee, Chun‐Yi Lee, Yi‐Ching Lo, Chi‐Fa Hung, Cheng‐Sheng Chen · 2021 · The World Journal of Biological Psychiatry
98. The evaluation of a physical health promotion intervention for people with severe mental illness receiving community based accommodational support: a mixed-method pilot study
    Viola Sofie Kirschner, Natalie Lamp, Ümmügülsüm Dinc, Thomas M Becker, Reinhold Kilian, Annabel Sandra Mueller‐Stierlin · 2022 · BMC Psychiatry
99. Offering physical activity advice to people with serious mental illness: The beliefs of mental health professionals
    Sandra Leyland, Alan Currie, Steven Anderson, Eddie Bradley, Jonathan Ling · 2018 · Mental health and physical activity
100. The effectiveness of structured exercise programmes on psychological and physiological outcomes for patients with psychotic disorders: A systematic review and meta-analysis
     Caitlin Fox‐Harding, Claire Tompsett, Ross Howard Sanders, Stephen Paul Cobley · 2018 · International Journal of Sport and Exercise Psychology